Michael Golembiewski
2022
In 2022, Michael Golembiewski earned a total compensation of $1.1M as Chief Financial Officer at Apricus Biosciences, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $126,850 |
|---|---|
| Option Awards | $616,800 |
| Salary | $317,125 |
| Other | $10,852 |
| Total | $1,071,627 |
Golembiewski received $616.8K in option awards, accounting for 58% of the total pay in 2022.
Golembiewski also received $126.9K in non-equity incentive plan, $317.1K in salary and $10.9K in other compensation.
Rankings
In 2022, Michael Golembiewski's compensation ranked 2,846th out of 5,542 executives tracked by ExecPay. In other words, Golembiewski earned more than 48.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,846 out of 5,542 | 49th |
Division Manufacturing | 1,581 out of 3,000 | 47th |
Major group Chemicals And Allied Products | 729 out of 1,350 | 46th |
Industry group Drugs | 679 out of 1,253 | 46th |
Industry Pharmaceutical Preparations | 490 out of 907 | 46th |
Source: SEC filing on April 12, 2023.
Golembiewski's colleagues
We found one more compensation record of an executive who worked with Michael Golembiewski at Apricus Biosciences in 2022.
2022
Raj Mehra
Apricus Biosciences